Vilnius University Hospital Santaros Klinikos
- Address
- Nephrology center (Corps D, 1 Floor), Santariskiu str. 2, LT-08661 Vilnius, Lithuania
Immune System Diseases Research
At Vilnius University Hospital Santaros Klinikos, clinical research is focused on immune system diseases, with particular attention to rare kidney-related inflammatory disorders that affect the glomeruli. The trials are designed to better understand disease behavior and evaluate new treatment options for patients with limited therapeutic choices.
- Studies in C3 glomerulopathy and idiopathic immune complex-mediated glomerulonephritis
- Research aimed at assessing the safety and tolerability of new therapies
- Clinical work exploring how investigational treatments may help improve disease control in rare immune-mediated kidney disease
The site’s research activity in Vilnius reflects a strong focus on advancing care for uncommon nephrology conditions through studies that look at both treatment effects and patient safety.
Rare Kidney Disease Trials
This research program centers on C3 glomerulopathy, a rare form of glomerular disease linked to immune system dysfunction. The trials are evaluating investigational therapies to see whether they can offer meaningful benefit for patients by improving disease management and supporting better long-term outcomes.
- Testing new treatment approaches for C3G and related glomerulonephritis
- Evaluating how well emerging therapies are tolerated and how safely they can be used
- Studying the potential effects of novel medicines on immune-mediated kidney inflammation
With only a small number of trials underway, the Nephrology center is contributing to focused research on rare diseases that may help shape future treatment options in Lithuania and beyond.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Eleva GmbH1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vilnius University Hospital Santaros Klinikos
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of CPV-104 Pharmacokinetics, Safety, and Tolerability in Healthy Subjects and Patients with C3 Glomerulopathy | Eleva GmbH | Phase I | Recruiting | Jun 2025 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Oms906 | 1 | Unknown | 2024-01-29 | 2024-01-29 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.